|
Andrea Cohen’s practice is centered around investments in private equity investment vehicles and their formation and the representation of investors and emerging technology companies in the clean technologies and life sciences sectors.
Ms. Cohen advises fund managers on matters relating to organization, offshore jurisdictional issues, ongoing operations and management, as well as with respect to structuring investments in venture and private-equity-backed companies.
A significant number of the investors Ms. Cohen counsels are public entities and funds of funds that require a thorough understanding of issues particular to them, such as ERISA, FOIA, and other regulatory matters and policy considerations.
Ms. Cohen represents investors in matters relating to private equity, general corporate, and securities law matters, including mergers and acquisitions, private equity, and venture capital and start-up and venture capital-backed clean technology and life sciences companies on formation, equity and debt financing, restructurings, board and management issues, licensing, mergers and acquisitions, and general corporate and commercial transactional matters.
Recent Publications • “Differences between Cayman Islands and Delaware Limited Partnerships”, NP Private Equity Newsletter (2007) • “California and Other States Limit Disclosure of Fund Details”, NP Private Equity Alert (2006) Recent Presentations and Panels: • “Comparing Fee Structures Across the Asset Classes,” Strategic Research Institute, Ninth Annual Private Equity Roundup, January 2007, Scottsdale • “Negotiating Terms With Limited Partners,” Private Equity Due Diligence Conference, December 2006, New York
|
